Literature DB >> 27518722

Triflusal : A Viewpoint by José P. De La Cruz.

J P De La Cruz1.   

Abstract

Year:  1998        PMID： 27518722     DOI： 10.2165/00003495-199855060-00012

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  5 in total

1.  Effects of triflusal and acetylsalicylic acid on platelet aggregation in whole blood of diabetic patients.

Authors:  J P De la Cruz; J Pavia; J Garcia-Arnes; F Sanchez de la Cuesta
Journal:  Eur J Haematol       Date:  1988-03       Impact factor: 2.997

2.  Triflusal vs aspirin on the inhibition of human platelet and vascular cyclooxygenase.

Authors:  J P de la Cruz; J M Mata; F Sanchez de la Cuesta
Journal:  Gen Pharmacol       Date:  1992-03

3.  Effect of triflusal and acetylsalicylic acid on platelet aggregation in human whole blood: influence of red blood cells and leukocytes.

Authors:  J P de la Cruz; J Pavia; I Bellido; F Sánchez de la Cuesta
Journal:  Methods Find Exp Clin Pharmacol       Date:  1988-06

4.  Effects of triflusal and its main metabolite HTB on platelet interaction with subendothelium in healthy volunteers.

Authors:  J P De La Cruz; M A Villalobos; P J García; J M Smith-Agreda; F Sánchez de la Cuesta
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

5.  Platelet antiaggregatory effect of triflusal in human whole blood.

Authors:  J P de la Cruz; J Pavia; I Bellido; M C González; F Sánchez de la Cuesta
Journal:  Methods Find Exp Clin Pharmacol       Date:  1988-04
  5 in total
  1 in total

Review 1.  Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation.

Authors:  David Murdoch; Greg L Plosker
Journal:  Drugs       Date:  2006       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.